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We present a model for the interaction dynamics of lymphocytes-tumor cells population. This
model reproduces all known states for the tumor. Futherly, we develop it taking into account
periodical immunotheraphy treatment with cytokines alone. A detailed analysis for the evolution
of tumor cells as a function of frecuency and theraphy burden applied for the periodical treatment
is carried out. Certain threshold values for the frecuency and applied doses are derived from this
analysis. So it seems possible to control and reduce the growth of the tumor. Also, constant values
for cytokines doses seems to be a succesful treatment.
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I. INTRODUCTION
Cancer is one of the leading research areas, since this
desease is a main cause of death. Surgery and chemother-
apy are unsuccessful in many cases. Today the principal
efforts are addressed to search new treatment strategies
e.g. in immunotherapy (see Refs. [1,2] and references
therein). In this case we refer to the use of cytokynes
to stimulate the immune system. This is a protein hor-
mone produced by activated lymphocytes which mediate
both natural and specific immunity. The use of cytokines
alone to boost the immune system represent one of the
methods more commonly used in immunotherapy. The
temporal evolution for this treatment comprises differ-
ent steps: by supplying a starting dose of cytokines the
rate of lymphocytes begins to increase due to the im-
munological reaction [1] reaching a maximum value; af-
terwards the lymphocytes begin to decay because of the
decrease of cytokines concentration inside the body until
it reaches normal values. In the following we shall call
this time the activation period of the immune system.
This proccess repeats again between any two succesive
dose suplies. We consider these injections separated in
time by the dosage period. Otherwise, it would provoke
an overdose or failure in the treatment for shorter and
longer time, respectively.
This work is devoted to understand the temporal tumor
behavior when a periodical immunotherapy treatment is
provided. Besides, we want to explore the set of parame-
ter values to reproduce with our model the same features
presented in [2](like short tem oscillation in tumor size
and long term tumor relapse).
For this reason we reformulate the predator-prey model
including new terms in the model which give account of
tumor agressiveness, the diffusion of lymphocytes and the
effect caused by cytokines on the tumor (Section 2). We
analyse the model from the mathematical and biological
points of view (Sections 3 and 4). We study in detail
tumor evolution for different treatment regimes (Section
5) and, in the last section, we discuss our results and
suggest some options for improving the model.
II. THE MODEL
An extensive review of all models of tumor-immune
system dynamics [2–12] as far as we know was done. We
agree with the idea that such dynamics is determined
by a competence of interacting species resembling the
predator-prey model. The main difference between our
model and the clasical deterministic model (e.g. Bell
1973) [4] is the inclusion of new terms taking into ac-
count, (1) the death of lymphocytes due to the increase
of malignant cells population, (2) the flux of lymphocytes
towards the place of local interaction and (3) the effect
produced by the application of cytokine doses.
Let X and Y denote respectively the number of malig-
nant and lymphocyte cells. The rate of malignant cells(
dX
dt
)
is given by:
dX
dt
= aX − bXY (1)
We assume a growth rate proportional to X and a de-
crease rate proportional to the frecuency of interaction
with lymphocytes. Coefficients are a and b, respectively,
where a is tissue dependent.
On the other hand, the growth rate of lymphocytes(
dY
dt
)
is described by:
dY
dt
= dXY − fY − kX + u (2)
It is proportional to the interaction with malignant cells
and also to the flux per unit time of lymphocytes to the
place of interaction. These effects are represented by the
first and fourth terms in the right-hand side of equation
1
2. This last term characterizes the difussion process of
lymphocytes that takes place in the surroundings of the
tumor assuming a constant lymphocytes flux [7]. On the
other hand, the decrease rate depends on two factors:
natural death and growth of malignant cells related to
the effective area of tumor interacting directly with the
lymphocytes. These are given by the second and third
terms of this same equation where f and k are their re-
spective coefficients of proportionality.
In order to introduce the effects produced by the treat-
ment with cytokines in the proccess of activation of the
immune system, we add a periodical function that mim-
ics the periodical dosage. As a first approximation, we
propose the function F cos2 ωt, where ω is the frecuency
of the periodical behavior for cytokines inside the body.
The modified Eq 2 will be given by the expression
dY
dt
= dXY − fY − kX + u+ F cos2 ωt (3)
Taking into account Eq.1, we get the following system
of differential equations.
dX
dt
= aX − bXY (4)
dY
dt
= dXY − fY +Q (5)
Q = − KX + u+ Fcos2(ωt) (6)
where Q is a function that picking up all the news con-
tributions respecting the standard predator-prey model.
with X(0) = X0 and Y (0) = Y0 as initial conditions.
From the analysis for Q = 0 the system of Eq.4,
Eq.5and Eq.6 reduces to the predator-prey model, which
has as equilibrium points a saddle point at the phase
portrait origin and a center in the first quadrant of the
phase diagram [13]. This center reflects the oscillating
behavior of the competence between both predator and
prey, which is characterized by an oscillation frecuency
(number of cycles per unit time around the center of the
phase diagram). Taking the reverse of this frecuency as
a characteristic time t0 =
1√
af
and rescaling the equa-
tions of the system of Eq.4, Eq.5and Eq.6 by means of
the following scaling parameters:
t = t0τ
X = X ′x
Y = Y ′y
the system given by the Eq.4, Eq.5and Eq.6 become:
X ′
t0
x˙ = axX ′ − bxyX ′Y ′ (7)
Y ′
t0
y˙ = (dxX ′ − f)yY ′ +Q (8)
Q = F cos2(ω t0τ) + u−K X ′x (9)
sustituting the scaling parameters by the following
values:
t0 =
1√
af
X ′ =
√
af
d
Y ′ =
√
af
b
we get the following rescaled equations
dx
dτ
= α x− xy (10)
dy
dτ
= xy − 1
α
y − kx+ σ + V cos2(β τ) (11)
with x(0) = x0 and y(0) = y0 as initial conditions.
where V = Fb
af
, k = K
bd
√
af ,
α =
√
a
f
, σ = ub
af
and β = ω√
af
Analysing in detail the prior expressions we can interpret
these parameters as follows:
From V it is deduced that its value depends on the
net value for doses (F ) and on the action of the immune
system on malignant cells (b). Hence it would represent
an effective value of all doses employed in the activation
of lymphocytes, namely, those necesary for activating the
lymphocytes that take action directly against the tumor
cells.
On the one hand, k is directly proportional to K which
accounts for the negative effects exerted on the popula-
tion of lymphocytes due to the size of the tumor and it
is inversely proportional to the recognition (d) and at-
tack (b) frequencies of the immune systen to malignant
cells. So, we infer that the inverse value of this parameter
(1/k) gives, “in some sense”, the control exerted by the
immune system over the aggressiveness of the tumor due
to its size.
From the similarity of the expressions for σ and V , taking
into account the remarks done for V we interpret that
σ which depends on the action of the immune system
on malignant cells (b) represent of all lymphocytes flux
u those effective value involved in the attack on tumor
cells. Finally, α and β are directly related to the prolifer-
ation of malignant cells and the frecuency of treatment,
respectively.
III. DYNAMICS AND STABILITY ANALYSIS
WITHOUT TREATMENT
The system of Eq.10 and Eq.11 corresponding to V =
0( no treatment) is an autonomous system given by the
following equations:
dx
dτ
= α x− xy (12)
dy
dτ
= xy − 1
α
y − kx+ σ (13)
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with x(0) = x0 and y(0) = y0 as initial conditions.
Susbstituting the Eq.12 in the Eq.13 we get the differen-
tial equation
d2x
dτ2
+ (
1
α
− x− 1
x
dx
dτ
)
dx
dτ
= (k − α)x2 + σx (14)
with x(0) = x0, x˙(0) = v0 as initial conditions.
This equation is similar to that describing the motion
of a particle in a force field [12], whose potential is:
U(x) = −1
3
(k − α)x3 − 1
2
σx2 (15)
This potential has two extremes given by
x1 = 0 and x2 =
σ−1
k−α
These extreme points depend on α, k and σ as:
σ > 1→


x1 = 0 minimum
k
α
> 1, x2 > 0 maximum
k
α
< 1, x2 < 0 maximum
and for
σ < 1→


x1 = 0 maximum
k
α
> 1, x2 > 0 minimum
k
α
< 1, x2 < 0 minimum
We only consider motion for x > 0, the suitable potential
fields describing the motion of the particle are depicted in
Fig. 1a and Fig. 1b. In Fig. 1a , the maximum represents
an unstable point for the particle motion, contrary in Fig.
1b the particle oscillates around the minimum.
The analysis of fixed points in the phase space for Eq.12
and Eq.13 shows two steady-states. A fixed point is L0 =
(0, ασ) with associated eigenvalues
λ± =
α2(1− σ)− 1
2α
±
∣∣∣∣α2(1 − σ) + 12α
∣∣∣∣ (16)
For σ < 1, L0 is a saddle point while for σ > 1 is a stable
node.
The other fixed point is L1 =
(
1−σ
α−k
, α
)
with associated
eigenvalues given by:
λ± =
k − ασ
2α(α− k) ±
√[
k − α σ
2α(α− k)
]2
− (1 − σ) (17)
The real part of this eigenvalue is zero for k
α
= σ with
v0 < 1.
When condition (α−k)2− k
α
> −1 is fulfilled, we get two
values for σc solutions of
α2σ2c − 2α[k − 2α(α− k)2]σc + k2 − 4α2(α− k)2 = 0
given by
σc =
k
α
− 2α2
(
1− k
α
)2
±2α|1− k
α
|
√
α2
(
1− k
α
)2
− k
α
+ 1 (18)
defining the region of complex eigenvalues and focus-like
behavior.
The analysis of these eigenvalues provides a rich dy-
namics. For the case k
α
< 1 we have different situations.
The states and its stability for the second fixed point are
depicted schematically in Fig. 2.
If σ < k
α
(Reλ± > 0), we have an unstable focus or node
depending on the parameter value σc relative to those
given by Eq.18.
On the contrary, stable behavior (focus or node) appears
when k
α
< σ < 1 (Reλ± < 0).
Now, if 1 < σ the fixed point corresponds to a negative
population of malignant cells, with no physical meaning.
For the case k
α
> 1 and σ < 1 < k
α
(Reλ± < 0) the
critical point moves to the second quadrant of the phase
diagram, being discarded as before.
For values of σ in the ranges 1 < σ < k
α
and 1 < k
α
< σ we
get a saddle point (λ+ > 0 and λ− < 0), whose separatrix
splits the phase portrait into stable and unstable zones
as can be seen in Fig.5. In all the cases the dynamics
in the phase diagram is represented by a homeomorfism
[14] between two fixed points.
IV. BIOLOGICAL SIGNIFICANCE
So far, we have presented a detailed analitical study
of the linear stability of our model when V is set equal to
zero. The interpretation of this preliminary results will
give us the esential features of the system.
Let us start with the case k
α
< 1.
For σ < k
α
the system evolves towards a state of uncon-
trolable tumor growth(see Fig. 3a) This case can be inter-
preted as a recurrence like behavior [15,16] very similar
to q-switching oscillations observed in physical phenom-
ena as, for example, in lasers. On the contrary, when
k
α
< σ < 1, our system evolves towards a controlable
mass of malignant cells in a damped oscillating way (Fig.
3b). This state is considered by some authors as a dor-
mant state [7–9,15,16].
However in both cases, there exist populations of malig-
nant cells that grow towards a state in which immunolog-
ical activity has been suppressed. In the first case this
happens for any initial conditions, while in the second
it only happens for an initially weak inmunological re-
sponse (Fig. 4a and 4b). Let us now analyse the reverse
condition k
α
> 1.
In this case there are two possible ranges for σ:
1 < k
α
< σ and 1 < σ < k
α
In both situations we are in the presence of a saddle
point which means that for populations of cancer cells be-
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low the horizontal separatrix the dynamics is irreversible:
this curve represents the critical amount of malignant
cells for a fixed population of lymphocytes.
This situation is similar to the case analised before for a
weak immnune system as an initial condition: the popu-
lation of malignant cells grows towards a value such that
the immunological response is reduced to zero (Fig. 5).
This would represent a state where illness is not the cause
of death but leaves the body unprotected against other
diseases.
However for malignant cells above the horizontal separa-
trix it is possible to observe regression of tumor as has
been reported in clinical experiments(see Ref. [15] and
references therein)
V. STABILITY ANALYSIS WITH TREATMENT
AND BIOLOGICAL IMPLICATIONS
The system represented by Eq.10 and Eq.11 with
V 6= 0 (cytokines doses amplitude) can be analised as
an autonomous system [17]. The procedure consists in
substituting the oscillating function cosβt of the driven
term F cos2 βt in the Eq.11 by a new variable u, which
is a solution of the second order differential equation of
a linear oscillator
d2u
dt2
+ β2u = 0 (19)
(where u(0) = 1, u˙(0) = 0) which can be written as two
linear coupled differential equations
dz
dτ
= −β2u (20)
du
dτ
= z (21)
(with u(0) = 1, z(0) = 0)
Then Eq.10 and Eq.11 become:
dx
dτ
= α x− xy (22)
dy
dτ
= xy − 1
α
y − kx+ σ + V u2 (23)
dz
dτ
= −β2u (24)
du
dτ
= z (25)
with x(0) = x0, y(0) = y0, u(0) = 1, z(0) = 0 as initial
conditions.
This system presents the critical points L∗0 = (0, ασ, 0, 0)
and L∗1 =
(
1−σ
α−k
, α, 0, 0
)
whose projection in the y-x
plane coincides with those critical points of the unper-
turbed system (Eq.12 and Eq.13) with the same eigenval-
ues given by the Eq.16 and Eq.17 plus the new conjugate
pair λ± = ± iβ.
In this case we are in presence of a center manifold
where solutions can be expanding or contracting, i.e., the
asymptotic stability analysis carried out before loses its
validity, needing more complex developments.
In order to avoid such complexity and gain a better com-
prehension, we may consider this system like a couple of
one linear (Eq.19) and one nonlinear (Eq.14) oscillators,
allowing us a more intuitive interpretation of the differ-
ent regimes. Thus the changes from recurrent to dormant
states of tumor cells in the periodical dosage regime can
be interpreted as a lock of the unstable oscillations of the
nonlinear oscillator imposed by the linear one. We can
understand the complex behavior of coupled oscillators
by representing its dynamics as a function of control pa-
rameters V and β [17,18]. In order to depict it we plot,
in the parameter space (V vsβ), those points for which
tumor growth is uncontrolable.
In the case k
α
< 1 for σ < k
α
, for effective value of doses
and frecuencies higher than certain threshold, the sys-
tem can revert from uncontrolable growth to a treatment
controled population. Namely, for every set of parameter
values α,k and σ, there are threshold values for β and V
which split the parameter space (see Fig 6) into two zones
corresponding to uncontrolable and controlable growth of
malignant cells. The Fig 6 was generated for a fixed set of
initial conditions. Although the behavior of the param-
eter space for different initial conditions is qualitatively
the same, the threshold values show strongh dependence
of the initial conditions.
From this result and taking into account the meaning of
the parameters β and V , we can infer that treatment is
specific for each patient and kind of tumor since thresh-
old doses values depend on the immunological response of
each individual, on the malignant cells population at the
begining of the treatment and also on the rate of prolif-
eration of the tissue. Besides, the existence of threshold
values reflects the fact that reaching controlable popula-
tions of malignant cells is only possible by mantaining a
minimal dose above certain threshold given by the con-
tinuous line depicted in Fig 6, which can be well fitted
by a hiperbolic function.
For effective doses and frecuencies below these thresh-
old values, the system behaves qualitatively the same as
without treatment. However, contrary to this statement
it is also found that for low frecuencies the growth of ma-
lignant cells can be controlled in spite of being below the
threshold values (see, for details, Fig 6).
There exists a ”paradoxical” phenomenon observed in
experiment and the clinic, consisting in the fact that the
enhacement of the inmune system with immunotherapy
stimulates tumor growth [19], which could be explained,
“in some way”, by this result, i.e., why, for fixed doses
burden , the growth becomes uncontrolable at given fre-
cuencies above those localized in the region of controlable
growth of malignant cells (Fig. 6). Such values would rep-
resent an optimal treatment as it reduces doses burden
and treatment frecuency.
Also, for higher frecuencies with small V , growth of can-
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cer cells can be controlled as shown in Fig 6. The obser-
vance of these optimal values would be important because
of the negative effects produced when cytokines concen-
tration reaches above a critical concentration [20,21]..
Now, increasing the amplitud of the effective dose value
for a fixed frecuency above the threshold, a malignant
cells population reduction is obtained, in spite of an un-
controlable growth being observed for some higher doses
burden (see Fig 6).
On the other hand, setting V to some value and varying
the frecuency from zero to higher values, different behav-
iors are reproduced. At zero treatment frecuency, tumor
cells population is controlable with the lowest values of
doses burden (Fig. 6). However, for frecuencies different
from zero, we find zones of recurrent and dormant growth
of tumor cells. The population of cancer cells controled
under treatment presents an oscillating behavior (see Fig.
7) [2].
For values of the parameters satisfying k
α
< σ < 1 (that
we interpret as a dormant state), malignant cells popu-
lation can be reduced by increasing effective doses. On
the other hand, varying the frecuency for fixed effective
doses values, an oscillating behavior for the population
of malignant cells is obtained, as in the previous case.
In all these cases, regrowth of malignant cells takes place
after treatment interruption [9]. This can be easily un-
derstood if we take into account that the population of
malignant cells with zero value (x = 0) represents, in the
mechanical analogue (Eq.14), an unstable point (a po-
tential maximum, as that shown in Fig. 1b). This means
that any variation will lead the system towards a minimal
potential position. Therefore for a residual population
slightly greater than zero, a regrowth of tumor cells will
take place after the treatment.
Analysing the behavior when k
α
> 1 we arrive at the fol-
lowing results. The range of values with physical sense
for σ, i.e. 1 < k
α
< σ and 1 < σ < k
α
allows only two
critical points: a stable node and a saddle point. In this
case dynamics in the phase portrait is the same as that
without treatment. There are no possible changes in the
dynamics, so treatment is useless.
Hence, for k
α
> 1, only initial conditions determine the
final outcome of tumor evolution, irrespective of the ap-
plied treatment.
VI. CONCLUSIONS
In this work we intend to give a new focus to the
dynamics of tumor growth in a periodical regime of im-
munotherapy. We explain such dynamics considering this
system as two coupled oscillators, namely, the compe-
tence between the immune system and malignant cells
analized as a nonlinear oscillator coupled with a linear
one that simulates the treatment.
This simple model allowed us to describe all possible
states in wich a tumour can be found. It also presented
some of the features found in tumor dynamics, outlined
by some authors, such as the existence of short term os-
cillations of tumor size as well as the long term tumor
relapse. On the other hand, this model gives the depen-
dence of tumor growth on some parameter values related
to the treatment: the frecuency and amount of applied
doses. We conclude from this study that the evolution of
tumor submitted to immunotherapy has a strong depen-
dence on these parameter values.
In some cases, growth of malignant cells can be reverted
with inmunotherapy treatment. Corresponding thresh-
old values are obtained for treatment frequency and dose
above which growth is stopped and malignant cells pop-
ulation reduced.
Also, for those inmunological parameters for which a sta-
ble population of malignant cells exists, the size of the
dormant tumor can be reduced by increasing dose bur-
den.
It was shown, as well, that for certain relation among
the parameter values, tumor presents a recurrent behav-
ior with or without treatment.
In all these cases, when a reduction of the tumor is pos-
sible, best results are obtained for low constant values of
the dose. Nevertheless in all cases previously analyzed,
after the interruption of the treatment, tumor regrowth
is observed.
This would confirm the fact that treatment with im-
munotherapy using cytokines alone is not succesful
enough in the treatment against cancer [2]. Therefore
another kind of therapy would be required.
As a way to improve the model, we propose the intro-
duction of other terms taking into account effects pro-
duced by stochastic perturbations due to enviromental
conditions [6,7,11]. Some authors atribuit to these per-
turbations the main cause of possible jumps from stable
to unstable behavior in tumor growth dynamics. This
will be considered in a future work.
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FIG. 1. Potential barriers in which the particle moves. (a)
α = 1, k = 1.5 and σ = 3. (b) α = 2, k = 0.2 and σ = 0.25 ..
FIG. 2. States and its stability for the second fixed point
as a function of parameters α, k, σ.
FIG. 3. Evolution of malignant cells on time without treat-
ment. (a) α = 2, k = 0.2 and σ = 0.05 with x0 = 2.1 and
y0 = 2.7. (b) α = 2, k = 0.2 and σ = 0.25 with x0 = 5.3 and
y0 = 6.7.
FIG. 4. Phase portraits (lymphocytes population versus
malignant cells). (a) α = 2, k = 0.2 and σ = 0.09. (b)
α = 2, k = 0.2 and σ = 0.25.
FIG. 5. Saddle point in the phase portrait for values of
parameters α = 1, k = 1.5, σ = 3.
FIG. 6. Growth behavior of malignant cells with treat-
ment for α = 2, k = 0.2 and σ = 0.05 with
x0 = 5.3 and y0 = 6.7 depicted in the parameter space
(V , β). Uncontrolable growth (gray points). Controlable
growth (white points). Black solid line (hiperbolic function
V = 0.10478 + 0.00044/(0.05343 + β)2.7313).
FIG. 7. Limit cycles for V = 0.25 and different values of
parameter β in the phase portrait.
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